Dr. Girish Budhrani recognised with ACOIN Gujarat Chapter Oration
ACOIN has recognized Dr. Budhrani's exceptional work in promoting community and clinical ophthalmology
ACOIN has recognized Dr. Budhrani's exceptional work in promoting community and clinical ophthalmology
Target identification will commence on 17 September 2024, following the timeline provided in the campaign guidelines
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
The wP-IPV-based hexavalent vaccination is an innovative immunization alternative to the current pentavalent and standalone IPV vaccines
ALS patients experience neuroinflammation and rapid neurodegeneration
Lilly will license certain baricitinib manufacturing know-how to enable EVA Pharma to manufacture and supply treatment for various immunological diseases
Coal India has committed to providing upto Rs. 3 crore to treat thalassaemia and aplastic anaemia patients for a period of 3 years
The conference aims to bring various stakeholders and experts in the field of healthcare and digital solutions for ensuring ‘universal access to affordable and quality healthcare’
Innovative product offerings to capitalise on emerging opportunities within and beyond the sexual wellness market
H.coagulans is, unlike other general lactobacillus, characterized by spore formation, giving it resistance to acid and heat
Subscribe To Our Newsletter & Stay Updated